Form 4 for URGN UroGen Pharma Ltd.
Accepted 2021-12-02 00:00:00 ET · period of report 2021-11-30 · accession 0001209191-21-067439 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-02 | 2021-11-30 | URGN | Henderson Molly | CFO | S - Sale+OE | $12.03 | -2,587 | 4,913 | -34% | -$31.1K |
| D | 2021-12-02 | 2021-11-30 | URGN | Henderson Molly | CFO | M - OptEx | — | +5,000 | 7,500 | +200% | — |
| D | 2021-12-02 | 2021-11-30 | URGN | Henderson Molly | CFO | M - OptEx | $0.00 | -5,000 | 10.0K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2021-11-30 | S | D | 2,587 | $12.03 | 4,913 | D | — | — | (F2) Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units |
| 2 | Common | Ordinary Shares | 2021-11-30 | M | A | 5,000 | — | 7,500 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer |
| 3 | Derivative | Restricted Stock Units | 2021-11-30 | M | D | 5,000 | $0.00 | 10,000 | D | — · — to — | 5,000 Ordinary Shares | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer (F3) 1/3 of the shares underlying the stock options will vest on each of November 30, 2021, October 1, 2022 and October 1, 2023. |